Read More 5 minute read Pharma Industry News Sun Pharmaceutical faces regulatory pause as EMA application for melanoma drug withdrawn Sun Pharmaceutical’s EU partner Philogen has withdrawn its EMA application for Nidlegy, delaying regulatory progress in melanoma care. Read what’s next. byPallavi MadhirajuJune 26, 2025